medline.ch Onkologie

	The Immunomodulatory Effect of Various Anesthetic Factors and Techniques on Patients Undergoing Breast Cancer Surgery: A Systematic Review and Meta-analyses of RCTs. Clin Breast Cancer Mavropoulos P, Konstantis G, Tsaousi G, Baka S, Ziaka V, Tseriotis VS, Tsimtsiou Z, Pourzitaki C. PMID: 42829296 [PubMed - as supplied by publisher]
	Diversity within: a systematic review of intratumor heterogeneity in head and neck squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Nayyar V, Rachel J B, Kumar S, N SK, Malhotra R, Singh H, Pal D, Surya V, Mishra D. PMID: 42829295 [PubMed - as supplied by publisher]
	Doppler-based Radiomics Integrated With Frozen Section Analysis Enhances Borderline Ovarian Tumor Prediction: A Multicenter Study. Ultrasound Med Biol Zhang S, Wang W, Liu X, Lou X, Xu L, Yang J, Hu X, Lv B, Sun L, Chen J, Qin J. PMID: 42829281 [PubMed - as supplied by publisher]
	Re: Sobia Khan, Nathan Papa, Andrew Kneebone, et al. Prospective Comparison of (64)Copper [(64)Cu]SAR-bisPSMA vs (68)Gallium [(68)Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol 2026;89:512-20. Eur Urol Hindié E, Callaud A, Morgat C. PMID: 42829270 [PubMed - as supplied by publisher]
	Reply to Paolo Zaurito's Letter to the Editor re: Robert M. Meier, Nima Aghdam, Alan C. Beckman, et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029. Eur Urol Meier R, Aghdam N, Kaplan I. PMID: 42829268 [PubMed - as supplied by publisher]
	Reply to Riccardo Lombardo's Letter to the Editor re: Bi-Ming He, Keqin Zhang, Zhien Zhou, et al. Cognitive Versus Software-based Fusion targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.06.020. Eur Urol He BM, Wang HF. PMID: 42829267 [PubMed - as supplied by publisher]
	PSMA-PET/CT-guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT): 5-yr Analysis of a Phase 2 Randomized Controlled Trial. Eur Urol Belliveau C, Saad F, Duplan D, Petit C, Delouya G, Lambert C, Taussky D, Barkati M, Beauchemin MC, Clavel S, Mok G, Gauthier-Paré AS, Igidbashian L, Jolicoeur M, Nguyen TV, McLaughlin PY, Wong P, Keu KV, DaSilva JN, Juneau D, Ménard C. PMID: 42829266 [PubMed - as supplied by publisher]
	Re: Microultrasonography-guided Versus MRI-guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial. Eur Urol Girometti R, Giganti F. PMID: 42829264 [PubMed - as supplied by publisher]
	Clinical Landscape of Microbiome Modulators in Gynecological Tumor Treatment: From Pre-Clinical to Clinical Trials. Biomed J Zhang J, Jiang X, Lin Z, Li H, Jiang S. PMID: 42829202 [PubMed - as supplied by publisher]
	Immunosenescence in tumor progression: from synergistic mechanisms to therapeutic strategies. Crit Rev Oncol Hematol Chang F, Dong C, Li B. PMID: 42829195 [PubMed - as supplied by publisher]
	Transarterial Radioembolization for Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria: A Single-Center Retrospective Cohort Study. J Vasc Interv Radiol Baek TW, Kim GH, Ko E, Kim J, Sung C, Park HJ, Kim S, Chu HH, Kim JH, Gwon DI. PMID: 42829106 [PubMed - as supplied by publisher]
	Geographic Accessibility and Calendar Period in Gynecologic Cancer Stage at Diagnosis (Reply to Letter-to-the-Editor). Am J Obstet Gynecol Desjardins MR. PMID: 42829090 [PubMed - as supplied by publisher]
	Interpreting the specialist-access gradient in gynecologic cancer stage at diagnosis (Letter-to-the-Editor). Am J Obstet Gynecol Sun W, Wei L. PMID: 42829088 [PubMed - as supplied by publisher]
	Fragility Analysis Should Complement Statistical Reporting in Thrombosis Trials: Lessons from Reduced-Dose Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism. J Thromb Haemost Chow R, Talwar S, Beniwal M, Abdulrehman J, Gross PL. PMID: 42829086 [PubMed - as supplied by publisher]
	KRAS Mutation and Venous Thromboembolism Risk in Colorectal Cancer: A Danish Population-Based Cohort Study. J Thromb Haemost Wheler J, Troelsen FS, Vágó EK, Horváth-Puhó E, van Es N, Moik F, Ay C, Sørensen HT. PMID: 42829084 [PubMed - as supplied by publisher]
	When RNA Wears a Sugar Coat: Emerging Biology and Cancer Relevance of GlycoRNA. Cancer Lett Ren T, Lin Z, Xie W, Peng R, Wang L. PMID: 42829068 [PubMed - as supplied by publisher]
	Combining Antiviral Therapy with Cancer Treatment in HBV-associated HCC: A Translational Approach. Virus Res Hashem MA, Kayesh MEH, Kohara M, Tsukiyama-Kohara K. PMID: 42829048 [PubMed - as supplied by publisher]
	Engineering smart polymeric lipid nanoparticles for breast cancer: The convergence of AI and medical personalization to enhance efficacy and safety. Int J Pharm Sayed U, Azamova D, Abdulqader AF, Kadhim AA, Jamuna KV, Singhal D, Tailor NK, Polatova D. PMID: 42829010 [PubMed - as supplied by publisher]
	Cervical cancer survival analysis by integrating multi-omics data through an adaptive weighted deep neural network. Comput Biol Chem Zheng J, Su Z, Zhuo X, Chai H, Tang H, Lan T. PMID: 42828972 [PubMed - as supplied by publisher]
	Harnessing Annona muricata phytochemicals for multi-target cancer therapy: An integrated network pharmacology and in-silico study. Comput Biol Med Patil SM, Das A, Asgaonkar K, Rajagopal K, Avalaskar A, Gundecha G, Shevate K, Gavali P, Bhosale P. PMID: 42828951 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 1978060

Seite 1 von 98903

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung